Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
One Hundred Flowers is an invention and disruption consultancy led by Don Smith. The firm helps organizations embrace invention, with activities spanning clean energy, health-tech, and climate change prevention. Their first spin-out was the "1nhaler," now an independent start-up. They developed "Concept Theory," a strategic model for inventing/innovating and measuring idea value—applied to increase success rates of data-driven entrepreneurial ventures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on One Hundred Flowers.